{"brief_title": "A Study of the Safety and Efficacy Interferon-Gamma 1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)", "brief_summary": "Study GIPF-001 is phase 3 study designed to determine the safety and efficacy of IFN-g 1b administered by subcutaneous injection; compared to placebo in patients with IPF who are unresponsive to steroids. 330 patients have been enrolled and were assigned to either a IFN-g 1b group or a placebo group.", "condition": "Idiopathic Pulmonary Fibrosis", "intervention_type": "Drug", "intervention_name": "Interferon-gamma 1b", "description": "200 mcg, SQ, 3x per week", "criteria": "Male or Female, 20-79 years old", "gender": "All", "minimum_age": "20 Years", "maximum_age": "79 Years", "healthy_volunteers": "No", "id": "NCT00047645.xml"}